Karyopharm Therapeutics Statistics
Total Valuation
KPTI has a market cap or net worth of $195.97 million. The enterprise value is $401.85 million.
| Market Cap | 195.97M |
| Enterprise Value | 401.85M |
Important Dates
The last earnings date was Thursday, May 14, 2026, before market open.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KPTI has 22.55 million shares outstanding. The number of shares has increased by 72.20% in one year.
| Current Share Class | 22.55M |
| Shares Outstanding | 22.55M |
| Shares Change (YoY) | +72.20% |
| Shares Change (QoQ) | +38.04% |
| Owned by Insiders (%) | 2.92% |
| Owned by Institutions (%) | 54.20% |
| Float | 14.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.30 |
| Forward PS | 1.46 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.78 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -40.62% |
| Return on Invested Capital (ROIC) | -123.26% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 11.09% |
| Revenue Per Employee | $662,798 |
| Profits Per Employee | -$855,127 |
| Employee Count | 228 |
| Asset Turnover | 1.17 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, KPTI has paid $8,000 in taxes.
| Income Tax | 8,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +93.54% in the last 52 weeks. The beta is 0.82, so KPTI's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | +93.54% |
| 50-Day Moving Average | 8.33 |
| 200-Day Moving Average | 7.20 |
| Relative Strength Index (RSI) | 50.02 |
| Average Volume (20 Days) | 485,446 |
Short Selling Information
The latest short interest is 5.28 million, so 23.40% of the outstanding shares have been sold short.
| Short Interest | 5.28M |
| Short Previous Month | 5.29M |
| Short % of Shares Out | 23.40% |
| Short % of Float | 35.89% |
| Short Ratio (days to cover) | 12.69 |
Income Statement
In the last 12 months, KPTI had revenue of $151.12 million and -$194.97 million in losses. Loss per share was -$14.19.
| Revenue | 151.12M |
| Gross Profit | 20.33M |
| Operating Income | -84.21M |
| Pretax Income | -194.96M |
| Net Income | -194.97M |
| EBITDA | -83.92M |
| EBIT | -84.21M |
| Loss Per Share | -$14.19 |
Balance Sheet
The company has $90.85 million in cash and $296.73 million in debt, with a net cash position of -$205.88 million or -$9.13 per share.
| Cash & Cash Equivalents | 90.85M |
| Total Debt | 296.73M |
| Net Cash | -205.88M |
| Net Cash Per Share | -$9.13 |
| Equity (Book Value) | -265.65M |
| Book Value Per Share | -11.78 |
| Working Capital | 114.52M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 292,000 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 13.45%, with operating and profit margins of -55.73% and -129.02%.
| Gross Margin | 13.45% |
| Operating Margin | -55.73% |
| Pretax Margin | -129.01% |
| Profit Margin | -129.02% |
| EBITDA Margin | -55.53% |
| EBIT Margin | -55.73% |
| FCF Margin | n/a |
Dividends & Yields
KPTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -72.20% |
| Shareholder Yield | -72.20% |
| Earnings Yield | -99.49% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for KPTI is $13.50, which is 55.35% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.50 |
| Price Target Difference | 55.35% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 16.34% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 26, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Feb 26, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |